Skip to content

Linchuan Liao

4 papers in the library · 4 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

Samm50 Downregulation-Driven Mitochondrial Dysfunction Triggers Ferroptosis and Contributes to Ketamine-Induced Neurotoxicity and Cognitive Impairment.

Neuropharmacology September 18, 2026 Yuanlong Li, Xiangyun Dai, Junmei Hu et al.

Ketamine abuse is associated with persistent cognitive deficits and neurotoxicity, though the underlying mechanisms remain incompletely understood. While mitochondrial dysfunction and ferroptosis have been separately implicated, their causal relationship and the key molecular link in ketamine-induced hippocampal damage are unclear. Using a mouse model of ketamine-induced cognitive impairment...

DOI: 10.1016/j.neuropharm.2026.111192 (opens in new tab) Full text (opens in new tab) Ketamine Cognitive impairment Ferroptosis Hippocampal neurotoxicity +2

Non-targeted and Targeted Metabolomics Techniques Reveal Striatal Metabolome Characteristics in the Ketamine-Induced Conditioned Place Preference Mice Model.

Journal of Molecular Neuroscience July 12, 2025 Weihao Fan, Yi Ye, Hongkun Yang et al. 1 citation

Ketamine is a synthesized anesthetic drug that was used extensively as a surgical anesthetic in the 1960s. Currently, ketamine is being investigated extensively for its potential as a treatment for depression. However, the addictive nature of ketamine has become an issue that cannot be ignored at this stage. As of now, there is no clear understanding of the changes in striatal metabolites and...

DOI: 10.1007/s12031-025-02382-z (opens in new tab) Full text (opens in new tab) Ketamine addiction ketamine Rewire the brain Neurotransmitters neurotransmitters Kynurenine +9

The immune regulatory mechanism of ketamine-induced psychiatric disorders: A new perspective on drug-induced psychiatric symptoms.

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 10, 2025 Peipei Wang, Junmei Hu, Congliang Chen et al. 2 citations

Ketamine, a psychoactive substance strictly regulated by international drug conventions, is classified as a "new type drug" due to its excitatory, hallucinogenic, or inhibitory effects. The etiology of ketamine-induced psychiatric symptoms is multifaceted, with the immune regulatory mechanism being the most prominent among several explanatory theories. In recent years, the interaction between...

DOI: 10.1016/j.pnpbp.2024.111194 (opens in new tab) Full text (opens in new tab) New drugs Ketamine therapy Neuroimmunology research Psychiatric treatment +2

The amino acid metabolism pathway of peripheral T lymphocytes and ketamine-induced schizophrenia-like phenotype.

Journal of Psychiatry and Neuroscience 2024 Peipei Wang, Linzhi Jiang, Junmei Hu et al. 1 citation

The intricate interplay between peripheral adaptive immune cells and the central nervous system (CNS) has garnered increasing recognition. Given that alterations in cell quantities often translate into modifications in metabolite profiles and that these metabolic changes can potentially traverse the bloodstream and enter the CNS, thereby modulating the progression of mental illnesses, we sought...

DOI: 10.1503/jpn-240038 (opens in new tab) Full text (opens in new tab) Schizophrenia research Amino acid metabolism Immunology Ketamine studies